Title Cold ischemia time and graft fibrosis are associated with autoantibodies after pediatric liver transplantation: a retrospective cohort study of the European Reference Network TransplantChild /
Authors Junge, Norman ; Di Giorgio, Angelo ; Girard, Muriel ; Demir, Zeynep ; Kaminska, Diana ; Janowska, Maria ; Urbonas, Vaidotas ; Varnas, Dominykas ; Maggiore, Giuseppe ; Alterio, Tommaso ; Leiskau, Christoph ; Vondran, Florian W. R ; Richter, Nicolas ; D’Antiga, Lorenzo ; Mikolajczyk, Rafael ; Pfister, Eva-Doreen ; Baumann, Ulrich
DOI 10.3390/children9020275
Full Text Download
Is Part of Children.. Basel : MDPI. 2022, vol. 9, no. 2, art. no. 275, p. [1-11].. eISSN 2227-9067
Keywords [eng] T-cell mediated rejection ; liver biopsy ; de novo autoimmune hepatitis ; graft fibrosis ; chronic rejection ; antinuclear antibody ; smooth muscle antibody ; liver-kidney-microsome antibody ; pediatric liver transplantation
Abstract [eng] The reported prevalence of autoantibodies (AAB) (ANA, SMA, LKM, SLA) after pediatric liver transplantation (pLTX) varies considerably from 26–75%, but their clinical impact on outcome is uncertain. We aimed to study the prevalence of AAB after pLTX, their association with donor-, transplant-, and recipient-characteristics, and their relation to outcome. In our multicenter retrospective study, we aimed to clarify conflicting results from earlier studies. Six ERN TransplantChild centers reported data on 242 patients, of whom 61% were AAB positive. Prevalence varied across these centers. Independent of the interval between pLTX and AAB analysis, a one-hour increase in CIT resulted in an odds ratio (OR) of 1.37 (95% CI 1.11–1.69) for SMA positivity and an OR of 1.42 (95%CI 1.18–1.72) for ANA positivity. Steroid-free immunosuppression (IS) versus steroid-including IS (OR 5.28; 95% CI 1.45–19.28) was a risk factor for SMA positivity. Liver enzymes were not associated with ANA or SMA positivity. We did not observe an association of rejection activity index with ANA or SMA. However, the liver fibrosis score in follow-up biopsies was associated with ANA titer and donor age. In conclusion, this first multicenter study on AAB after pLTX showed high AAB prevalence and varied widely between centers. Longer CIT and prednisolone-free-IS were associated with AAB positivity, whereas AAB were not indicative of rejection, but instead were associated with graft fibrosis. The detection of AAB may be a marker of liver fibrosis and may be taken into consideration when indications for liver biopsy and immunosuppressive regimes, or reduction of immunosuppression in long-term follow-up, are being discussed. Prospective immunological profiling of pLTX patients, including AAB, is important to further improve our understanding of transplant immunology and silent graft fibrosis.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2022
CC license CC license description